By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


iBio, Inc. 

9 Innovation Way
Suite 100
Newark  Delaware  19711  U.S.A.
Phone: 302-355-0650 Fax: 302-356-1173


Company News
New Chinese iBioModulator Patent Joins iBio, Inc. (IBIO) Vaccine Portfolio 9/30/2015 12:27:41 PM
iBio, Inc. (IBIO) Anti-Fibrosis Portfolio Expanded To Include Orally Delivered Peptides 9/24/2015 12:24:44 PM
iBio, Inc. (IBIO) Fibrosis Therapeutics Program Receives NIH Grant Support 9/10/2015 12:13:18 PM
iBio, Inc. (IBIO) To Receive U.S. Patent For Influenza Therapeutic 8/11/2015 11:08:49 AM
iBio, Inc. (IBIO) Release: Three Recent iBioLaunch Platform Achievements To Be Presented At PBVAB 2015 Conference In Lausanne, Switzerland 6/9/2015 11:30:36 AM
Vaccine Improvement Patent Awarded To iBio, Inc. (IBIO) 5/4/2015 9:16:26 AM
iBio, Inc. (IBIO) Arranges Production Of IBIO-CFB03 For Clinical Development With Caliber Biotherapeutics 4/27/2015 11:32:19 AM
iBio, Inc. (IBIO) European Plague Vaccine Patent Emerges From Opposition Period 4/1/2015 3:47:59 PM
iBio, Inc. (IBIO) Adds Anthrax Antibodies To Product Pipeline 2/25/2015 2:01:21 PM
iBio, Inc. (IBIO) Receives U.S. And European Patents For Protein Expression Technology 2/12/2015 11:52:36 AM